Biggest News Aggregation in the World
๐Ÿ“ฐ Decisiondx Diffdx News

Decisiondx Diffdx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Decisiondx Diffdx. Real-time updates on events, politics, business and more.

Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas

Renowned eye cancer expert and study investigator, Amy Schefler, M.D., will share early data from a study to explore the potential for developing a complementary test that would be tailored for...
United States Decisiondx Diffdx Castle Biosciences Robert Cook Castle Bioscience Amy Schefler

Cancer Genetics (NASDAQ:CGIX) versus Castle Biosciences (NASDAQ:CSTL) Financial Review

Cancer Genetics (NASDAQ:CGIX – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap health care and social assistance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional […]
United States Castle Biosciences Decisiondx Diffdx Castle Bioscience Castle Biosciences Inc Vyant Bio Inc
Source: wkrb13.com

Financial Survey: Castle Biosciences (NASDAQ:CSTL) versus Cancer Genetics (NASDAQ:CGIX)

Castle Biosciences (NASDAQ:CSTL – Get Free Report) and Cancer Genetics (NASDAQ:CGIX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Institutional & Insider Ownership 85.8% of Castle […]
United States Castle Bioscience Castle Biosciences Decisiondx Diffdx Castle Biosciences Inc Vyant Bio Inc

Reviewing Castle Biosciences (NASDAQ:CSTL) and MedTech Acquisition (NASDAQ:MTAC)

MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Profitability This table compares MedTech Acquisition and […]
United States Castle Biosciences Decisiondx Diffdx Castle Bioscience Castle Biosciences Inc Medtech Acquisition Corporation
Source: wkrb13.com

Financial Contrast: MedTech Acquisition (NASDAQ:MTAC) versus Castle Biosciences (NASDAQ:CSTL)

MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of […]
United States Decisiondx Diffdx Castle Bioscience Castle Biosciences Medtech Acquisition Sponsor Medtech Acquisition Corporation

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Castle Biosciences to Host Investor Day on Sept. 20, 2022

Derek Maetzold, president and chief executive officer, Frank Stokes, chief financial officer, and other members of Castleโ€™s executive leadership team will provide an overview of the Companyโ€™s long-term corporate strategy, growth plans, research and development initiatives and financial outlook.
Derek Maetzold Castle Biosciences Frank Stokes Decisiondx Diffdx Texas Castle Biosciences Inc Castle Biosciences Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science